Key to universal flu vaccine: Embrace the unfamiliar
Vaccine researchers have developed a strategy aimed at generating broadly cross-reactive antibodies against the influenza virus: embrace the unfamiliar.
Aug 25, 2014
1
0
Vaccine researchers have developed a strategy aimed at generating broadly cross-reactive antibodies against the influenza virus: embrace the unfamiliar.
Aug 25, 2014
1
0
This year marks the centenary of the 1918 influenza pandemic, the worst flu outbreak in recorded history. A new study into the human, viral and societal factors behind its severity provides valuable lessons that could save ...
Oct 8, 2018
1
267
No matter the pathogen—virus, bacterium or fungus—many "pick a specific type of lock" on the surface of cells, which allows the microbe to break and enter into the inner sanctum of the host's genome.
The 2017-2018 flu season was historically severe. Public health officials estimate that 900,000 Americans were hospitalized and 80,000 died from the flu and its complications. For comparison, the previous worst season from ...
Oct 23, 2018
0
2
As the flu season approaches, a strained public health system may have a surprising ally—the common cold virus.
Sep 4, 2020
0
436
An experimental mRNA-based vaccine against all 20 known subtypes of influenza virus has provided broad protection from otherwise lethal flu strains in initial tests, and thus might serve one day as a general preventative ...
Nov 24, 2022
1
1596
New research by scientists at the University of Chicago suggests a person's antibody response to influenza viruses is dramatically shaped by their pre-existing immunity, and that the quality of this response differs in individuals ...
Dec 11, 2020
2
161
Microbes that live in the gut don't just digest food. They also have far-reaching effects on the immune system. Now, a new study shows that a particular gut microbe can prevent severe flu infections in mice, likely by breaking ...
Aug 3, 2017
3
1103
Strains of a common subtype of influenza virus, H3N2, have almost universally acquired a mutation that effectively blocks antibodies from binding to a key viral protein, according to a study from researchers at Johns Hopkins ...
Jul 10, 2020
1
212
An influenza vaccine administered through the nose and constructed with nanoparticles that enhance immune response offers strong protection against different influenza virus strains, according to researchers in the Institute ...
Jan 29, 2022
0
276